Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3736282
Max Phase: Preclinical
Molecular Formula: C36H55N7O6
Molecular Weight: 681.88
Molecule Type: Small molecule
Associated Items:
ID: ALA3736282
Max Phase: Preclinical
Molecular Formula: C36H55N7O6
Molecular Weight: 681.88
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CCCNC(=N)N)NC(=O)OCc1ccccc1)[C@@H](O)CC(=O)NCCc1ccccc1
Standard InChI: InChI=1S/C36H55N7O6/c1-24(2)21-29(30(44)22-31(45)39-20-18-26-13-8-6-9-14-26)41-33(46)32(25(3)4)43(5)34(47)28(17-12-19-40-35(37)38)42-36(48)49-23-27-15-10-7-11-16-27/h6-11,13-16,24-25,28-30,32,44H,12,17-23H2,1-5H3,(H,39,45)(H,41,46)(H,42,48)(H4,37,38,40)/t28-,29-,30-,32-/m0/s1
Standard InChI Key: GCFMVTIUTXZRPH-GKCWTWCASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 681.88 | Molecular Weight (Monoisotopic): 681.4214 | AlogP: 2.67 | #Rotatable Bonds: 20 |
Polar Surface Area: 198.97 | Molecular Species: BASE | HBA: 7 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.37 | CX Basic pKa: 11.89 | CX LogP: 2.67 | CX LogD: 0.44 |
Aromatic Rings: 2 | Heavy Atoms: 49 | QED Weighted: 0.06 | Np Likeness Score: 0.28 |
1. Gazdik M, O'Neill MT, Lopaticki S, Lowes KN, Smith BJ, Cowman AF, Boddey JA, Sleebs BE. (2015) The effect of N-methylation on transition state mimetic inhibitors of the Plasmodium protease, plasmepsin V, 6 (3): [10.1039/C4MD00409D] |
Source(1):